Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Novo Nordisk Invests US$2.3 billion (DKK 15.9 billion) to Expand Manufacturing Facilities
Novo Nordisk plans for the expansion of current Active Pharmaceutical Ingredient API production facility in Denmark This expansion supports the development of future portfolio of treatments for serious chronic diseases
Chongqing Zhifei Invests US$13 milion (100 million RMB) to Open Innovative Product Incubation Centre in China
Chongqing Zhifei plans for the construction of new innovative product incubation centre
WuXi Biologics Expands Drug Manufacturing Capacity
WuXi Biologics plans to expand manufacturing capacity for drug substance and drug product
Chugai Pharmaceutical Invests US$0.35 billion (50 billion Yen) to Open New Manufacturing Facilities
Chugai Pharmaceutical has unveiled its plans to construct a new facility dedicated to the manufacturing of bioactive pharmaceutical ingredients APIs as well as an injection building The two facilities will be loacted in Japan
GenScript Biotech Expands New Manufacturing Facility in China
GenScript Biotech plans for the expansion of new manufacturing facility at Jiangsu, China The facility supports the oligonucleotide and peptide production
TriLink BioTechnologies to Open mRNA Manufacturing Facility
TriLink BioTechnologies plans to construct new mRNA manufacturing capabilities to serve latephase drug developers in the field of life sciences
GeminiBio Plans to Contruct New Liquid Manufacturing Facility
GeminiBio opens new cGMP bioprocess liquid manufacturing facility in California, USA
Meissner Corporation Invests US$250 million to Construct New Manufacturing Facility
Meissner Corporation plans to construct new manufacturing facility The new facility will be loacted at Georgia, USA
Cambrex Constructs New Stability Storage Facility in Belgium, Europe
Cambrex plans to construct new stability storage facility to the pharmaceutical, medical device and life sciences industries across Europe
Catalent Invests US$20 million to Expand in Schorndorf, Germany
Introduction Catalent invests US$20 million to expand its clinical supply facility The new facility will be located in Schorndorf, Germany
